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angioplasty and stenting: Analysis of captured
particulate debris, ultrasound characteristics, and
prior carotid endarterectomy
Rajesh K. Malik, MD, Gregg S. Landis, MD, Scott Sundick, MD, Neal Cayne, MD, Michael Marin, MD,
and Peter L. Faries, MD, New York, NY
Introduction: Extracranial carotid stenoses exhibit significant variance in embolic potential, with restenotic lesions having
a particularly low propensity for embolization. This study sought to identify characteristics associated with increased
generation of embolic debris during carotid angioplasty and stenting (CAS).
Methods:Captured particulate was available for analysis in 56 consecutive patients. Demographics were mean age, 74 years
(range, 60-94 years); mean stenosis, 88% (range, 70%-99%); symptomatic, 27%; prior carotid endarterectomy (CEA),
27%; prior radiotherapy, 7%. Plaque echogenicity, heterogenicity, ulceration, and irregularity were assessed with B-mode
duplex ultrasound analysis. Gray scale median (GSM) was calculated from normalized B-mode VHS video recordings.
Calcification and degree of stenosis were determined angiographically. Captured particulate debris was evaluated for total
number; number >200 m, >500 m, >1000 m; mean and median size. Hematoxylin and eosin, trichrome, and von
Kossa stains were used for histologic analysis of captured material.
Results: Restenotic carotid stenoses after prior CEA generated minimal embolic debris compared with primary stenoses.
Four of 15 patients (27%) with restenotic lesions demonstrated embolic particles; all debris was<500m. All 41 patients
with primary stenoses had some embolic debris; particulate size was>200 m in 91%,>500 m in 72%, and>1000 m
in 43%. In primary lesions, the number and size of captured particulate correlated with GSM and with the combined
ultrasound findings of echogenicity, heterogenicity, and luminal irregularity/ulceration (P < .02, 95% confidence
interval, 4.5-27.6). None of these ultrasound factors correlated independently with embolic particulate (P  NS).
Patients aged>70 years exhibited more total particles (8.1 vs 2.3, P .008) and increased mean particle size (370 vs 157
m, P  .02). No significant correlation was observed between the number and size of captured embolic particulate and
any other variable (stenosis percentage, prior radiotherapy, preprocedural symptoms, periprocedural symptoms, and
calcification). Histologically, the embolic debris consisted of extensive amorphous, acellular proteinaceous material.
Calcium debris in the embolic particulate was associated with heavily and moderately calcified lesions.
Conclusions: Considerable variation exists in the number and size of embolic particles generated during CAS. Embolic
potential is positively correlated with lesion GSM and the combination of lesion echogenicity, heterogenicity, and
irregularity. Restenosis after prior CEA is associated with minimal embolic particulate generation, suggesting that
embolic protection may not be necessary for CAS of restenotic lesions. ( J Vasc Surg 2010;51:317-22.)Atherosclerotic disease of the carotid artery is a fre-
quent cause of ischemic strokes, resulting in substantial
morbidity and death each year in the United States. Each
year 700,000 new strokes are diagnosed, and nearly
150,000 patients die as a result of stroke.1 Approximately
20% to 30% of these strokes are caused by atheromatous
disease of the carotid artery.2
Carotid endarterectomy (CEA) emerged during the
past 50 years as the standard treatment to reduce the risk of
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doi:10.1016/j.jvs.2009.08.063a cerebrovascular event (CVA) in patients with high-grade
occlusive disease of the extracranial carotid artery. Carotid
angioplasty and stenting (CAS) is currently being used as an
alternative to CEA, particularly in patients considered at
increased risk for standard surgery; however, the safety of
CASwith regard to periprocedural cerebrovascular events is
the subject of ongoing investigation. Embolization of ath-
eromatous and thrombotic debris during angioplasty and
stent deployment represents one of the significant risks of
this procedure.
Multiple factors increase the risk of embolization from
carotid lesions. Investigators have shown that anatomic
considerations and plaque characteristic are likely the
patient-dependent factors that lead to the generation of
debris.3 Tortuosity, severe angulation, anomalous vessel
origins, and diffuse plaque burden are all potential sources
of emboli. Most of these factors are correlated with increas-
ing age.4,5 A more important finding is that the character-
istics of the carotid lesion itself have been correlated with
embolic potential. Intraplaque hemorrhage and echolucent
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with increased rates of symptomatic presentation in patients
undergoing CEA. In addition, restenotic intimal hyperplas-
tic carotid lesions that occur after CEA are associated with
lower rates of symptomatic presentation compared with
primary atherosclerotic carotid stenosis.
This study evaluated the relationship between the size
and number of embolic debris retained in the embolic filter
during CAS procedures with lesion type (primary or rest-
enotic), lesions characteristics, and patient age.
MATERIALS AND METHODS
Patients. Institutional Review Board approval was ob-
tained prior to the commencement of this study. An anal-
ysis was done of the captured embolic debris in 56 consec-
utive unselected embolic protection filters used during
CAS procedures performed by a single vascular surgeon.
The patients for whom captured particulate material was
available were a mean age of 74 years (range, 60-94 years).
Procedures were performed for primary atherosclerotic oc-
clusive disease in 41 of the 56 patients (73%), and 15 (27%)
underwent CAS for restenosis after a prior CEA (all patients
had undergone CEA 2 years of developing restenosis).
Medical comorbidities placing patients at high risk for
CEA were present in 79%, and 7% had undergone external
beam radiotherapy for the treatment of a cervical malig-
nancy. Symptoms were present in 15 of the 56 patients
(26%), including transient ischemic attack in 3, amauro-
sis fugax in 5, minor CVAs in 8, and 1 patient had
combined symptoms of amaurosis fugax and CVA. There
was no increase in the percentage of symptomatic pa-
tients aged 70 years.
CAS procedure. All procedures were in a hybrid an-
giographic operating room (Siemens AG, Munich, Ger-
many). Patients were pretreated with clopidogrel (75
mg/d) for 5 days or received a single loading dose (450
mg) 4 hours before the procedure. The procedure was
performed with the aid of local anesthesia, under fluoro-
scopic guidance through a common femoral arterial punc-
ture site. All patients received systemic heparinization (100
U/kg), and activated clotting time values were monitored
throughout the course of the procedure, with supplemental
heparin given for values 250 seconds.
Embolic protection devices were used in all patients,
including EPI FilterWire (Boston Scientific, Natick, Mass),
Accunet (Guidant, Minneapolis, Minn), and Angioguard
(Cordis, Somerville, NJ). Stents implanted included the
Wallstent (Boston Scientific), NexStent (EndoTex, Cuper-
tino, Calif), Acculink (Guidant), and Precise (Cordis). The
choice of embolic protection device and stent was deter-
mined by vessel anatomy, operator preference, and clinical
trial participation.
The embolic protection devices and stents were deliv-
ered through a 6F transfemoral sheath placed in the com-
mon carotid artery. The lesion was crossed initially with the
embolic protection device and was predilated with a 4- 
40-mm angioplasty balloon (Long VIVA, Boston Scien-tific). Postdilation was performed using a 5- to 6-mm 
20-mm angioplasty balloon (Gazelle, Boston Scientific).
Filter preparation. The exterior surface of the em-
bolic protection device was wiped with moistened gauze
after retrieval (Fig 1). Filters were then rinsed with saline,
blotted dry, and fixed in a 10% neutral buffered formalin
solution for 24 hours. Photomicrographs were taken of the
interior of the filters and used to determine the number and
size of individual particles. Irregularly shaped particles were
measured along their longest axis. Histologic analysis of
recovered material was performed with hematoxylin and
eosin and trichrome stains (Fig 2). Most plaques were
atheromatous—not fibrous—as indicated by preprocedural
ultrasound analysis. Von Kossa staining was used to deter-
mine the presence of calcification in the specimen (Fig 3).
Specimens were also analyzed using scanning and transmis-
sion electron microscopy.6 Energy-dispersive spectroscopy
was used to confirm the presence of calcium in the captured
embolic debris (Fig 4).
Gray scale median calculation. All patients under-
went a preprocedural duplex ultrasound (DU) examina-
tion. B-mode DU analysis was performed to assess plaque
echogenicity, heterogeneity, ulceration, and irregularity.
Echolucency can be measured using the gray scale median
(GSM), which is an objective and quantitative computer-
assisted grading of the echogenicity of carotid plaques. The
GSM was calculated using Photoshop (Adobe, San Jose,
Calif) from normalized B-mode DU VHS video record-
Fig 1. Captured particulate debris in filter.ings. Pixel analysis of the digitized plaque image (0 repre-
orpho
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generate a median value for all pixels in the image. Lesions
with higher GSM values have increased echogenicity, and
those with lower GSM values are more echolucent. Calci-
fication and degree of stenosis were determined angio-
graphically.
Statistical analysis. Patient demographics, lesion, and
captured particulate matter characteristics were prospec-
tively collected in a computerized database. Statistical anal-
ysis was performed using SPSS software (SPSS, Chicago,
Ill). Statistical significance was defined as P .05. The t test
was used for continuous variables, and Fisher’s exact test
was used for discrete variables.
RESULTS
Patient and lesion characteristics. Technical success
was achieved in all patients. The mean angiographically
determined internal carotid artery stenosis was 88% (range,
70%-99%). There was no outcome difference in relation to
the filter or stent used. Two patients aged 70 years had
mild intraoperative symptoms that resolved. There were no
Fig 2. Photomicrographs of hematoxylin and eosin st
right, bar, 60 m) of the captured particulate show am
Fig 3. The presence of calcium in the captured embolic debris
was correlated with preprocedural ultrasound imaging and angio-
graphic evidence of heavily and moderately calcified lesions (bar,
60 m).postprocedural CVAs.Primary vs restenotic lesions. Particulate matter
from 56 filters was analyzed. The procedures were for
primary atherosclerotic occlusive disease in 41 patients
(73%) and for restenosis after prior CEA in 15 (26%). All
patients with restenosis presented 2 years of the primary
procedure. Embolic debris was recovered from 100% of
primary lesions and 27% of restenotic lesions (P  .001).
The mean number of particles recovered in each specimen
correlated with lesion type (13.2 for primary vs 0.7 for
restenosis; P  .005; Table I).
A broad spectrum of particle sizes was recovered from
the filters. Embolic debris ranged in size from200 m to
1000 m. The mean captured particulate size among
primary atherosclerotic lesions was 382 m compared with
62 m from restenotic lesions (P .003; Table II). Owing
to limitations in filter pore sizes, small size particles might
have entered the brain, but the effect of this was unknown.
The distribution in number of particles closely correlated
with lesion type. A significant difference in particulate size
was observed between primary and restenotic lesions. De-
bris sizes 500 m and 1000 m were strongly corre-
lated with the primary atherosclerotic lesion type.
GSM analysis revealed that a score of 20 correlated
with increased echolucency and was associated with an
increase in the number and size of embolic particles (P 
.007). Prior studies have identified a GSM of 20 as the
threshold for increased embolic potential and decreased
plaque stability. In primary lesions, the number and size of
captured particulate correlated with GSM and with the
combined DU findings of echogenicity, heterogenicity,
and luminal irregularity/ulceration (95% confidence inter-
val, 4.5-27.6; P .02). The restenotic lesions tended to be
morphologically smoother, without ulceration or irregular-
ity. There was also a significant correlation between cap-
tured debris calcium and preprocedural and angiographic
evidence of calcium (P  .002).
Age and lesion characteristics. The patients were a
mean age of 74 years (range, 60-94 years). When these data
were correlated with lesion characteristics for the primary
atherosclerotic lesions for the 15 patients aged 70 years,
the mean number of particles per patient was 2.3, with a
under the dissecting microscope (left, bar, 300 m;
us, largely acellular proteinaceous material.ainingsize of 157 m (P  .008), whereas for the 26 patients
y con
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an increased mean size of 370 m (P .02; Table III). The
age of 70 was selected as the analysis point because this was
shown to be a clinically relevant threshold in previous
studies such as Carotid Revascularization Endarterectomy
vs Stent Trial (CREST). Mild intraoperative symptoms in
two patients aged 70 years resolved, and their filters had
large pieces of debris or were full of debris.
DISCUSSION
The periprocedural success of CAS depends on the rate of
embolization and thereby neurologic events. Plaque charac-
terization to determine embolic potential could be an impor-
tant first step in a process that may help guide physicians in
choosing appropriate procedures for patients with certain
plaque features. Severalmodalities could potentially guide this
characterization, including ultrasound imaging and magnetic
resonance imaging.
The results of studies that have looked at visible debris
in filter devices after CAS support routine filter protection.8
To our knowledge, no studies have correlated embolic
debris captured during CAS with preprocedural plaque
analysis. In this report, we have provided a microscopic anal-
ysis of filter debris in correlation with preprocedural ultra-
sound imaging, type of lesion, and patient age. We hope that
this will improve the understanding of the risk factors for
Fig 4. Energy dispersive spectroscop




Patients with embolic debris
No. (%) 500 m, % 1000 m, %
Primary 41 41 (100) 72 43
Restenosis 15 4 (27) 0 0
P .001 .001 .004embolization and aid in patient selection for CAS.Atherosclerosis is the pathologic entity responsible for
primary carotid disease in about 90% of patients, and enti-
ties such as such as fibromuscular dysplasia, kinking, extrin-
sic compression, dissections, and radiotherapy are the cause
in the remaining 10%. The atherosclerotic plaque consists
of a nodular deposition of fat that is primarily cholesterol
and highly prone to embolization. Restenotic plaques, on
the other hand, have two distinct pathologic plaque char-
acteristics, depending on the time interval. Early (2 years)
restenotic plaques result from intimal hyperplasia and are
characterized by the presence of smooth muscle cells,
with absence of atherosclerotic plaque characteristics
such as calcifications and a large lipid or necrotic core.9
This type of plaque is thought to be more stable and less
emboligenic. In contrast, late (2 years) carotid stenosis
is similar to primary carotid artery stenosis, with marked
macrophage infiltration, calcifications, and a lipid core,
and these plaques are considered as emboligenic as pri-
mary plaques.10
Our data analysis showed patients with primary athero-
sclerotic disease had embolic debris 100% of the time
compared with 27% of those with restenotic lesions, a
difference that was highly statistically significant. The pa-
tients with primary disease had an increased number of
particles (13.2) and a larger mean particle size (382 m)
compared with patients with restenotic lesions, which was
again highly statistically significant. This relates to the
theory that because primary lesions are more friable and
unstable, there is a larger risk of embolization during the
procedure compared with the early restenotic lesions.
Primary plaques in our study were mostly atheroma-
tous, whereas restenotic plaques tended to be smooth
and without ulceration or irregularity. There was a low
incidence in our restenotic group because they were early
presenters (2 years after their primary procedure), and
firmed presence of Ca2 (3.69 keV).their plaque would be expected to be less emboligenic.
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larger-sized debris particles and a greater number, no
correlation could be made with neurologic effect due to
the low number of intraoperative or postprocedural
events.
Preoperative evaluation of carotid plaque using ultra-
sound imaging may prove to be a valuable tool in planning
for the procedure. Previous studies have evaluated plaque
echolucency as measured by the GSM score in relation to
neurologic events and plaque characteristics ex vivo after
CEA. Grogan et al3 demonstrated with B-mode ultrasound
imaging that symptomatic plaques are more echolucent
and less calcified than asymptomatic plaques and are asso-
ciated with a greater degree of histopathologic plaque
necrosis. Echolucent plaques are also established as a risk
factor for neurologic events.11
An inverse relationship exists between carotid plaque
GSM values and necrotic core volume on histology, which
means that plaques with high necrotic core volume have
low GSM values. Prior studies have identified a GSM of 20
as the threshold for increased embolic potential and de-
creased plaque stability. This study showed that a GSM
20 correlated significantly with increased number and
size of embolic particles (P .007). This supports previous
studies that have shown that a low GSM value (more
echolucent) correlated with an increased embolic risk and
possible neurologic events.12
Interestingly, patients aged 70 years had a greater
number and larger-sized embolic particles than patients
aged 70 years (8.1 vs 2.3 and 370 vs 157 m), which was
statistically significant. There was no significant correlation
with the percentage of stenosis, prior radiotherapy, calcium,
and preprocedural or periprocedural symptoms (given the low
number of neurologic events). This implies that embolization
is more likely to occur during the procedure in patients aged
70 years, and this could potentially translate to increased
neurologic events and periprocedural stroke risk. Again, we
Table II. Number of debris particles correlates with lesion
Lesion type No. Total 200
Primary 41 13.2 8.5
Restenosis 15 0.7 0.3
P .005 .006 .0





70 38 2.3 157
70 18 8.1 370
P .008 .02selected an age of 70 as the analysis point because previousstudies, such as CREST, have shown this is a clinically
relevant threshold.
CONCLUSION
Our study shows considerable variation exists in the
number and size of embolic particles generated during
CAS. Embolic potential is positively correlated with lesion
GSM values and the combination of lesion echogenicity,
heterogeneity, and irregularity. Restenosis after prior CEA
is associated with minimal embolic particulate generation,
suggesting that embolic protection may be optional for
CAS of restenotic lesions. No significant correlation was
observed between the number and size of captured embolic
particulate and any other variable such as percentage of
stenosis, prior radiotherapy, preprocedural symptoms,
periprocedural symptoms, or calcification.1
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